GEDpm-cg

GEDpm-cg designs in-silico genomic single-nucleotide point mutations in Corynebacterium glutamicum to support precise genome editing workflows using suicide plasmid-mediated counter-selection and overlap-based DNA assembly for vector construction and experimental verification.


Key Features:

  • Comprehensive design capability: Generates precise designs for single-nucleotide edits at any locus on the C. glutamicum chromosome using a suicide plasmid-mediated counter-selection strategy combined with overlap-based DNA assembly.
  • High-throughput in-silico processing: Performs computational design tasks for over 10,000 single point mutations in approximately five minutes.
  • Primer and verification design: Produces primer sequences for overlap-based vector DNA assembly and for sequencing verification of edits.
  • Experimental validation: In-silico designs were validated by successful construction of three independent point mutations in C. glutamicum.

Scientific Applications:

  • Microbial cell factory development: Enables targeted genomic modifications in C. glutamicum for strain engineering.
  • Metabolic engineering: Supports precise single-nucleotide changes to optimize metabolic pathways.
  • Synthetic biology: Facilitates design and verification of genetic variants and engineered constructs.
  • Industrial strain optimization: Supports large-scale mutation analysis for industrial applications using C. glutamicum.

Methodology:

Uses computer-aided design tools to generate in-silico designs for suicide plasmid-mediated counter-selection, overlap-based DNA assembly for vector construction, and primer sequences for assembly and sequencing verification.

Topics

Details

Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
5/8/2022
Last Updated:
5/8/2022

Operations

Publications

Yang Y, Mao Y, Liu Y, Wang R, Lu H, Li H, Luo J, Wang M, Liao X, Ma H. GEDpm-cg: Genome Editing Automated Design Platform for Point Mutation Construction in Corynebacterium glutamicum. Frontiers in Bioengineering and Biotechnology. 2021;9. doi:10.3389/fbioe.2021.768289. PMID:34722482. PMCID:PMC8554027.